Advertisement
Screener

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

BRAINSTORM CELL THERAPEUTICS INC. Operating Cash Flow

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Operating Cash Flow of -$895.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14

  • BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$895.00K.
  • BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.32M.
  • BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$740.00K.
  • BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.10M.
  • BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2025 was -$6.97M.
  • BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2024 was -$9.09M.
  • BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2023 was -$20.46M.
  • BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2022 was -$19.32M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filedNet Cash Provided by (Used in) Operating Activities 129 monthNet Cash Provided by (Used in) Operating Activities 132 monthNet Cash Provided by (Used in) Operating Activities 135 monthNet Cash Provided by (Used in) Operating Activities 138 monthNet Cash Provided by (Used in) Operating Activities 141 monthNet Cash Provided by (Used in) Operating Activities 144 monthNet Cash Provided by (Used in) Operating Activities 147 monthNet Cash Provided by (Used in) Operating Activities 150 monthNet Cash Provided by (Used in) Operating Activities 153 monthNet Cash Provided by (Used in) Operating Activities 156 monthNet Cash Provided by (Used in) Operating Activities 159 monthNet Cash Provided by (Used in) Operating Activities 162 month
2026-06-30-$895.00K
10-Q · filed 2026-08-14
-$2.21M
10-Q · filed 2026-08-14
-$2.96M
derived: sum of 3 quarters · filed 2026-08-14
-$4.06M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31-$1.32M
10-Q · filed 2026-05-15
-$2.06M
derived: sum of 2 quarters · filed 2026-05-15
-$3.16M
derived: sum of 3 quarters · filed 2026-05-15
-$6.66M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31-$740.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$1.84M
derived: sum of 2 quarters · filed 2026-03-31
-$5.34M
derived: sum of 3 quarters · filed 2026-08-14
-$6.97M
10-K · filed 2026-03-31
2025-09-30-$1.10M
10-Q · filed 2025-11-14
-$4.60M
derived: sum of 2 quarters · filed 2026-08-14
-$6.24M
10-Q · filed 2025-11-14
-$7.28M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$3.50M
10-Q · filed 2026-08-14
-$5.13M
10-Q · filed 2026-08-14
-$6.18M
derived: sum of 3 quarters · filed 2026-08-14
-$9.48M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31-$1.63M
10-Q · filed 2026-05-15
-$2.68M
derived: sum of 2 quarters · filed 2026-05-15
-$5.98M
derived: sum of 3 quarters · filed 2026-05-15
-$7.66M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31-$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$4.35M
derived: sum of 2 quarters · filed 2026-03-31
-$6.03M
derived: sum of 3 quarters · filed 2026-03-31
-$9.09M
10-K · filed 2026-03-31
2024-09-30-$3.30M
10-Q · filed 2025-11-14
-$4.98M
derived: sum of 2 quarters · filed 2025-11-14
-$8.04M
10-Q · filed 2025-11-14
-$11.33M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30-$1.68M
10-Q · filed 2025-08-14
-$4.75M
10-Q · filed 2025-08-14
-$8.03M
derived: sum of 3 quarters · filed 2025-08-14
-$14.44M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$3.06M
10-Q · filed 2025-05-15
-$6.35M
derived: sum of 2 quarters · filed 2025-05-15
-$12.76M
derived: sum of 3 quarters · filed 2025-05-15
-$19.54M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$3.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$9.69M
derived: sum of 2 quarters · filed 2025-03-31
-$16.47M
derived: sum of 3 quarters · filed 2025-03-31
-$20.46M
10-K · filed 2025-03-31
2023-09-30-$6.41M
10-Q · filed 2024-11-14
-$13.19M
derived: sum of 2 quarters · filed 2024-11-14
-$17.17M
10-Q · filed 2024-11-14
-$21.82M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$6.78M
10-Q · filed 2024-08-14
-$10.76M
10-Q · filed 2024-08-14
-$15.41M
derived: sum of 3 quarters · filed 2024-08-14
-$20.26M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$3.99M
10-Q · filed 2024-05-14
-$8.63M
derived: sum of 2 quarters · filed 2024-05-14
-$13.48M
derived: sum of 3 quarters · filed 2024-05-14
-$19.62M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$4.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$9.50M
derived: sum of 2 quarters · filed 2024-04-01
-$15.63M
derived: sum of 3 quarters · filed 2024-04-01
-$19.32M
10-K · filed 2024-04-01
2022-09-30-$4.85M
10-Q · filed 2023-11-14
-$10.98M
derived: sum of 2 quarters · filed 2023-11-14
-$14.67M
10-Q · filed 2023-11-14
-$20.18M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$6.13M
10-Q · filed 2023-08-14
-$9.82M
10-Q · filed 2023-08-14
-$15.33M
derived: sum of 3 quarters · filed 2023-08-14
-$21.79M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$3.69M
10-Q · filed 2023-05-15
-$9.20M
derived: sum of 2 quarters · filed 2023-05-15
-$15.66M
derived: sum of 3 quarters · filed 2023-05-15
-$20.98M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$5.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
-$11.97M
derived: sum of 2 quarters · filed 2023-03-30
-$17.30M
derived: sum of 3 quarters · filed 2023-03-30
-$26.27M
10-K · filed 2023-03-30
2021-09-30-$6.46M
10-Q · filed 2022-11-14
-$11.79M
derived: sum of 2 quarters · filed 2022-11-14
-$20.76M
10-Q · filed 2022-11-14
-$28.34M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$5.33M
10-Q · filed 2022-08-15
-$14.30M
10-Q · filed 2022-08-15
-$21.88M
derived: sum of 3 quarters · filed 2022-08-15
-$28.80M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$8.97M
10-Q · filed 2022-05-16
-$16.55M
derived: sum of 2 quarters · filed 2022-05-16
-$23.47M
derived: sum of 3 quarters · filed 2022-05-16
-$29.13M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$7.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28
-$14.50M
derived: sum of 2 quarters · filed 2022-03-28
-$20.16M
derived: sum of 3 quarters · filed 2022-03-28
-$35.19M
10-K · filed 2022-03-28
2020-09-30-$6.92M
10-Q · filed 2021-11-15
-$12.59M
derived: sum of 2 quarters · filed 2021-11-15
-$27.61M
10-Q · filed 2021-11-15
-$30.89M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$5.66M
10-Q · filed 2021-08-05
-$20.69M
10-Q · filed 2021-08-05
-$23.97M
derived: sum of 3 quarters · filed 2021-08-05
-$27.59M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31-$15.03M
10-Q · filed 2021-04-26
-$18.31M
derived: sum of 2 quarters · filed 2021-04-26
-$21.93M
derived: sum of 3 quarters · filed 2021-04-26
-$25.44M
derived: sum of 4 quarters · filed 2021-04-26
2019-12-31-$3.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-04
-$6.90M
derived: sum of 2 quarters · filed 2021-02-04
-$10.41M
derived: sum of 3 quarters · filed 2021-02-04
-$11.25M
10-K · filed 2021-02-04
2019-09-30-$3.63M
10-Q · filed 2020-10-15
-$7.13M
derived: sum of 2 quarters · filed 2020-10-15
-$7.97M
10-Q · filed 2020-10-15
-$11.69M
derived: sum of 4 quarters · filed 2020-10-15
2019-06-30-$3.51M
10-Q · filed 2020-08-05
-$4.34M
10-Q · filed 2020-08-05
-$8.07M
derived: sum of 3 quarters · filed 2020-08-05
-$14.66M
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31-$835.00K
10-Q · filed 2020-05-07
-$4.56M
derived: sum of 2 quarters · filed 2020-05-07
-$11.15M
derived: sum of 3 quarters · filed 2020-05-07
-$11.10M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31-$3.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18
-$10.32M
derived: sum of 2 quarters · filed 2020-02-18
-$10.26M
derived: sum of 3 quarters · filed 2020-02-18
-$12.39M
10-K · filed 2020-02-18
2018-09-30-$6.59M
10-Q · filed 2019-11-14
-$6.54M
derived: sum of 2 quarters · filed 2019-11-14
-$8.66M
10-Q · filed 2019-11-14
-$11.60M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$55.00K
10-Q · filed 2019-08-13
-$2.07M
10-Q · filed 2019-08-13
-$5.01M
derived: sum of 3 quarters · filed 2019-08-13
-$1.16M
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31-$2.13M
10-Q · filed 2019-05-10
-$5.06M
derived: sum of 2 quarters · filed 2019-05-10
-$1.22M
derived: sum of 3 quarters · filed 2019-05-10
-$2.85M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31-$2.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$908.00K
derived: sum of 2 quarters · filed 2019-04-01
-$722.00K
derived: sum of 3 quarters · filed 2019-04-01
-$2.36M
10-K · filed 2019-04-01
2017-09-30$3.84M
10-Q · filed 2018-10-29
$2.21M
derived: sum of 2 quarters · filed 2018-10-29
$571.00K
10-Q · filed 2018-10-29
2017-06-30-$1.63M
10-Q · filed 2018-07-23
-$3.27M
10-Q · filed 2018-07-23
2017-03-31-$1.64M
10-Q · filed 2018-05-14
2016-12-31-$5.86M
10-K · filed 2018-03-08
2015-03-31-$1.94M
10-Q · filed 2015-05-14
-$3.94M
derived: sum of 2 quarters · filed 2015-05-14
-$5.06M
derived: sum of 3 quarters · filed 2015-05-14
-$6.03M
derived: sum of 4 quarters · filed 2015-05-14
2014-12-31-$2.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26
-$3.13M
derived: sum of 2 quarters · filed 2015-03-26
-$4.10M
derived: sum of 3 quarters · filed 2015-03-26
-$4.49M
10-K · filed 2015-03-26
2014-09-30-$1.12M
10-Q · filed 2014-11-13
-$2.09M
derived: sum of 2 quarters · filed 2014-11-13
-$2.48M
10-Q · filed 2014-11-13
-$4.09M
derived: sum of 4 quarters · filed 2015-05-14
2014-06-30-$970.00K
10-Q · filed 2014-08-12
-$1.36M
10-Q · filed 2014-08-12
-$2.97M
derived: sum of 3 quarters · filed 2015-05-14
-$3.68M
derived: sum of 4 quarters · filed 2015-05-14
2014-03-31-$391.00K
10-Q · filed 2015-05-14
-$2.00M
derived: sum of 2 quarters · filed 2015-05-14
-$2.71M
derived: sum of 3 quarters · filed 2015-05-14
-$3.77M
derived: sum of 4 quarters · filed 2015-05-14
-$18.73M
10-Q · filed 2014-05-13
2013-12-31-$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26
-$2.32M
derived: sum of 2 quarters · filed 2015-03-26
-$3.38M
derived: sum of 3 quarters · filed 2015-03-26
-$4.05M
10-K · filed 2015-03-26
-$18.34M
10-K · filed 2014-03-27
2013-09-30-$713.00K
10-Q · filed 2014-11-13
-$1.78M
derived: sum of 2 quarters · filed 2014-11-13
-$2.45M
10-Q · filed 2014-11-13
-$3.14M
derived: sum of 4 quarters · filed 2014-11-13
-$16.73M
10-Q · filed 2013-11-14
2013-06-30-$1.06M
10-Q · filed 2014-08-12
-$1.73M
10-Q · filed 2014-08-12
-$2.43M
derived: sum of 3 quarters · filed 2014-08-12
-$3.50M
derived: sum of 4 quarters · filed 2014-08-12
-$16.02M
10-Q · filed 2013-08-14
2013-03-31-$670.00K
10-Q · filed 2014-05-13
-$1.37M
derived: sum of 2 quarters · filed 2014-05-13
-$2.44M
derived: sum of 3 quarters · filed 2014-05-13
-$2.86M
derived: sum of 4 quarters · filed 2014-05-13
-$14.96M
10-Q · filed 2013-05-09
2012-12-31-$696.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27
-$1.77M
derived: sum of 2 quarters · filed 2014-03-27
-$2.19M
derived: sum of 3 quarters · filed 2014-03-27
-$2.94M
10-K · filed 2014-03-27
-$2.92M
10-K · filed 2013-03-14
-$14.29M
10-K · filed 2013-03-14
2012-09-30-$1.07M
10-Q · filed 2013-11-14
-$1.49M
derived: sum of 2 quarters · filed 2013-11-14
-$2.24M
10-Q · filed 2013-11-14
-$2.71M
derived: sum of 4 quarters · filed 2013-11-14
-$13.61M
10-Q · filed 2012-11-13
2012-06-30-$419.00K
10-Q · filed 2013-08-14
-$1.17M
10-Q · filed 2013-08-14
-$1.64M
derived: sum of 3 quarters · filed 2013-08-14
-$2.53M
derived: sum of 4 quarters · filed 2013-08-14
-$12.54M
10-Q/A · filed 2012-08-29
2012-03-31-$746.00K
10-Q · filed 2013-05-09
-$1.22M
derived: sum of 2 quarters · filed 2013-05-09
-$2.11M
derived: sum of 3 quarters · filed 2013-05-09
-$2.91M
derived: sum of 4 quarters · filed 2013-05-09
-$12.12M
10-Q · filed 2012-05-11
2011-12-31-$471.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14
-$1.37M
derived: sum of 2 quarters · filed 2013-03-14
-$2.17M
derived: sum of 3 quarters · filed 2013-03-14
-$2.22M
10-K · filed 2013-03-14
-$11.37M
10-K · filed 2012-03-15
2011-09-30-$897.00K
10-Q · filed 2012-11-13
-$1.70M
derived: sum of 2 quarters · filed 2012-11-13
-$1.75M
10-Q · filed 2012-11-13
-$2.30M
derived: sum of 4 quarters · filed 2012-11-13
-$10.90M
10-Q · filed 2011-11-14
2011-06-30-$800.00K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-29
-$855.00K
10-Q/A · filed 2012-08-29
-$1.40M
derived: sum of 3 quarters · filed 2012-08-29
-$1.80M
derived: sum of 4 quarters · filed 2012-08-29
-$10.00M
10-Q/A · filed 2011-09-07
2011-03-31-$55.00K
10-Q · filed 2012-05-11
-$601.00K
derived: sum of 2 quarters · filed 2012-05-11
-$1.00M
derived: sum of 3 quarters · filed 2012-05-11
2010-12-31-$546.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15
-$946.00K
derived: sum of 2 quarters · filed 2012-03-15
-$2.07M
10-K · filed 2012-03-15
2010-09-30-$400.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14
-$1.52M
10-Q · filed 2011-11-14
2010-06-30-$1.12M
10-Q/A · filed 2011-09-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
Pluri Inc. (PLUR)$0.014B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Passage BIO, Inc. (PASG)United States$0.015B-0.43
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37